Logos Global Management »

Cybin shares owned by Logos Global Management

Quarter-by-quarter ownership of Cybin (HELP) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Cybin

Tip: Access up to 7 years of quarterly data

All positions including Cybin held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin by Logos Global Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.0M 750k 6.61
2024-09-30 $5.3M 600k 8.89

More positions owned by Logos Global Management

Erasca (ERAS)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Ideaya Biosciences (IDYA)
Biontech Se Sponsored Ads (BNTX)
Vera Therapeutics Cl A (VERA)
Tango Therapeutics (TNGX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Dyne Therapeutics (DYN)
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Logos Global Management

Top funds holding Cybin

VR Adviser
OrbiMed Advisors
Adage Capital Partners GP
Millennium Management
Rosalind Advisors
Sphera Funds Management
Acorn Capital Advisors
DCF Advisers
Sio Capital Management
Morgan Stanley
Nan Fung Group Holdings
Boxer Capital Management
Citadel Advisors
Logos Global Management
Susquehanna International

View all funds holding Cybin